Epinephrine-induced Insulin Resistance in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Items 201–300 of 556
β-Adrenergic Receptor and Insulin Resistance in the Heart
Mangmool, S., Denkaew, T., Parichatikanond, W., & Kurose, H. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.128 · Cited by 54
“( Deibert and DeFronzo , 1980 ; Morisco et al .”
Abnormalities of autonomic nervous control in human hypertension
Julius, S. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877080 · Cited by 45
“First, it is known that beta-adrenergic stimulation causes a receptor-mediated insulin resistance [ 57 ].”
BackgroundDirect alpha-adrenergic stimulation of hepatic glucose production in human subjects
Rosen, S. G., Clutter, W. E., Shah, S. D., Miller, J. P., Bier, D. M., & Cryer, P. E. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.245.6.e616 · Cited by 43
Sakr, H. F., Sirasanagandla, S. R., Das, S., Bima, A. I. H., & Elsamanoudy, A. Z. (2023) · Biomedicines · doi:10.3390/biomedicines11082271 · Cited by 60
“A two-hour adrenaline injection reduced insulin sensitivity by more than 40% [33].”
BackgroundChronic variable stress improves glucose tolerance in rats with sucrose-induced prediabetes
Packard, A. E. B., Ghosal, S., Herman, J. P., Woods, S. C., & Ulrich-Lai, Y. M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.016 · Cited by 41
Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
Sleep Apnea–Hypopnea Syndrome and Type 2 Diabetes. A Reciprocal Relationship?
Martínez-Cerón, E., Mateos, R. C., & Rio, F. G. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.12.007 · Cited by 50
Gjedsted, J., Buhl, M., Nielsen, S., Schmitz, O., Vestergaard, E. T., Tønnesen, E., & Møller, N. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02316.x · Cited by 51
“It is clear that adrenaline effectively stimulates lipolysis and increases the concentrations of free fatty acid (FFA) (Baltzan et al. 1965) and leads to hyperglycaemia because of peripheral and hepatic insulin resistance (Deibert & Defronzo 1980).”
BackgroundMesmar, B., Poola-Kella, S., & Malek, R. (2017) · Endocrine Practice · doi:10.4158/ep171914.ra · Cited by 48
In vivo insulin action in genetic models of hypertension
Frontoni, S., Ohman, L. E., Haywood, J. R., DeFronzo, R. A., & Rossetti, L. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.2.e191 · Cited by 46
Self-citationObermaier, B., Ermel, B., Kirsch, D., Mushack, J., Rattenhuber, E., Biemer, E., Machicao, F. E., & Häring, H. (1987) · Diabetologia · doi:10.1007/bf00274578 · Cited by 42
“Catecholamines induce insulin resistance in man [1, 2 ], and it appears that this insulin resistance arises from a direct antagonism of catecholamines and insulin at the insulin sensitive tissues [3].”
BackgroundRegulation of Extramuscular Fuel Sources During Exercise
Wasserman, D. H., & Cherrington, A. D. (1996) · Comprehensive Physiology · doi:10.1002/cphy.cp120123 · Cited by 41
Cryer, P. E., Tse, T. F., Clutter, W. E., & SHAH, S. D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e198 · Cited by 47
Jensen, J., Ruge, T., Lai, Y., Svensson, M. K. E., & Eriksson, J. W. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.028 · Cited by 39
“It is well documented that adrenaline stimulates hepatic glucose release [13,36] and inhibits peripheral glucose uptake [4,13,32].”
BackgroundMethodSíndrome de apneas-hipopneas del sueño y diabetes tipo 2. ¿Una relación de ida y vuelta?
Martínez-Cerón, E., Mateos, R. C., & Rio, F. G. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.06.017 · Cited by 50
Itzhaki Ben Zadok, O., Kornowski, R., Goldenberg, I., Klempfner, R., Toledano, Y., Biton, Y., Fisman, E. Z., Tenenbaum, A., Golovchiner, G., Kadmon, E., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0582-y · Cited by 37
“This in turn increases insulin resistance and at the same time stimulates both gluconeogenesis and glycogenolysis [40, 41].”
BackgroundLi, M., Chen, G., Feng, Y., & He, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.676892 · Cited by 46
Paquot, N., Schneiter, P., Jéquier, E., & Tappy, L. (1995) · Clinical Physiology · doi:10.1111/j.1475-097x.1995.tb00514.x · Cited by 39
Heart Failure as a Risk Factor for Diabetes Mellitus
Guglin, M. E., Lynch, K. F., & Krischer, J. P. (2014) · Cardiology · doi:10.1159/000363282 · Cited by 39
Thermoneutrality modifies the impact of hypoxia on lipid metabolism
Jun, J. C., Shin, M., Yao, Q., Devera, R., Bevans‐Fonti, S., & Polotsky, V. Y. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00515.2012 · Cited by 41
“Glucose intolerance also occurred, which is a well-known consequence of SNS activation in rodents (67) and humans (16).”
Glucose, insulin and sympathoadrenal activation
Levin, B. E., & Sullivan, A. C. (1987) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(87)90152-4 · Cited by 39
Lönnroth, P., DAVIES, J. I., Lönnroth, I., et al. (1987) · Biochemical Journal · doi:10.1042/bj2430789 · Cited by 38
Julius, S. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087078 · Cited by 37
Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework
Sarnyai, Z., & Ben‐Shachar, D. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116220 · Cited by 43
“(During et al. 1995; Dunning et al. 1988; Baron et al. 1987; Deibert and DeFronzo 1980; Lembo et al. 1994).”
Qi, Z., & Ding, S. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0182 · Cited by 43
Impact of glucocorticoids on insulin resistance in the critically ill
Pretty, C. G., Chase, J. G., Lin, J., Shaw, G. M., Compte, A. L., Razak, N. N. A., & Parente, J. D. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.08.004 · Cited by 45
Interleukin-1 induced increases in glucose utilization are insulin mediated
Lang, C. H., & Dobrescu, C. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90078-7 · Cited by 36
Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats
Bhanot, S., Michoulas, A., & McNeill, J. H. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01075939 · Cited by 34
The effect of selective beta adrenergic blockade on glucose-induced thermogenesis in man
Thorin, D., Golay, A., Simonson, D. C., Jéquier, E., Felber, J. P., & DeFronzo, R. A. (1986) · Metabolism · doi:10.1016/0026-0495(86)90009-0 · Cited by 40
Self-citationSigal, R. J., Fisher, S. J., Halter, J. B., Vranić, M., & Marliss, E. B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6116 · Cited by 44
Abe, I., Islam, F., & Lam, A. K.-Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.593780 · Cited by 35
“In addition, Deibert and co-workers showed that insulin resistancewas increasedby excess catecholamine (8).”
BackgroundMetabolic actions of catecholamines in man
Webber, J., & Macdonald, I. A. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80181-8 · Cited by 38
Capaldo, B., Napoli, R., di Marino, L., & Saccá, L. (1992) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(92)90301-p · Cited by 36
Diabetic Ketoacidosis: Biochemistry, Physiology, Treatment, and Prevention
Krane, E. J. (1987) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36296-4 · Cited by 37
Metformin Decreases Blood Pressure and Obesity in OLETF Rats Via Improvement of Insulin Resistance.
Kosegawa, I., Katayama, S., Kikuchi, C., Kashiwabara, H., Negishi, K., Ishii, J., Inukai, K., & Oka, Y. (1996) · Hypertension Research · doi:10.1291/hypres.19.37 · Cited by 33
Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness
Lupien, J., Hirshman, M. F., & Horton, E. S. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.2.e210 · Cited by 37
CORRALL, R. J. M., FRIER, B. M., DAVIDSON, N. M., & FRENCH, E. B. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02117.x · Cited by 33
Effects of Increased Arterial Epinephrine on Insulin, Glucose and Phosphate
Kjeldsen, S. E., Moan, A., Pétrin, J., Weder, A. B., & Julius, S. (1996) · Blood Pressure · doi:10.3109/08037059609062103 · Cited by 32
Steenberg, D. E., Hingst, J. R., Birk, J. B., Thorup, A., Kristensen, J. M., Sjøberg, K. A., Kiens, B., Richter, E. A., & Wojtaszewski, J. F. P. (2020) · Diabetes · doi:10.2337/db19-1010 · Cited by 35
“Noradrenaline has been shown to decrease insulin sensitivity (42), and although we found higher levels of noradrenaline and adrenaline immediately after exercise, the levels were not different between the 2 days prior to initiation of the clamp.”
BackgroundMoan, A., Høieggen, A., Nordby, G., Os, I., Eide, I. A., & Kjeldsen, S. E. (1995) · Metabolism · doi:10.1016/0026-0495(95)90034-9 · Cited by 33
Solis‐Herrera, C., Daniele, G., Alatrach, M., Agyin, C., Triplitt, C. L., Adams, J. M., Patel, R., Gastaldelli, A., Honka, H., Chen, X., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2177 · Cited by 32
Self-citationKhoury, N., & McGill, J. B. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1212 · Cited by 35
Ferri, C., Laurenti, O., BELLINI, C., Cassone-Faldetta, M., Properzi, G., Santucci, A., & DEMATTIA, G. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00180-j · Cited by 30
Peripheral Adrenoceptors: The Impetus Behind Glucose Dysregulation and Insulin Resistance
Boyda, H. N., Procyshyn, R. M., Pang, C. C. Y., & Barr, A. M. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12002 · Cited by 34
Fenik, V. B., Singletary, T., Branconi, J. L., Davies, R. O., & Kubin, L. K. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00051 · Cited by 33
“Indeed, in addition to their blood pressure-elevating actions, catecholamines, and angiotensin II acutely suppress the counter-regulatory insulin response to high carbohydrate intake and glucose disposal (Deibert and DeFronzo, 1980; Ogihara et al., 2002; Vicini et al., 2002), and exacerbate the negative effects of oxi…”
BackgroundMackenzie, R., & Watt, P. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6934937 · Cited by 37
“In this study it was suggested that increased sympathetic nervous activity, in response to intermittent hypoxia, decreased glycogenesis, increased glycolysis, and diminished the ability of glucose to stimulate its own uptake and disposal [33, 34], which is a very confusingmessage.”
BackgroundMechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients
Prato, S. D., Riccio, A., de Kreutzenberg, S. V., Dorella, M., Avogaro, A., Marescotti, M. C., & Tiengo, A. (1993) · Metabolism · doi:10.1016/0026-0495(93)90167-m · Cited by 28
β‐adrenergic blockade and diabetes mellitus. A review
Östman, J. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb01616.x · Cited by 31
Metabolic syndrome: Aggression control mechanisms gone out of control
Belsare, P. V., Watve, M., Ghaskadbi, S., Bhat, D., Yajnik, C. S., & Jog, M. M. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.09.014 · Cited by 29
The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review
Abohelwa, M., Kopel, J. J., Shurmur, S. W., Ansari, M. M., Awasthi, S., & Awasthi, S. (2023) · Journal of Vascular Diseases · doi:10.3390/jvd2010010 · Cited by 62
High Heart Rate Relates to Clustering of Cardiovascular Risk Factors in a Screened Cohort.
Inoue, T., Oshiro, S., Iseki, K., Tozawa, M., Touma, T., Ikemiya, Y., & Takishita, S. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.969 · Cited by 27
Franssen, F. M. E., Sauerwein, H. P., Ackermans, M. T., Rutten, E. P. A., Wouters, E. F. �., & Schols, A. M. W. J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.004 · Cited by 28
“[27] Deibert DC, DeFronzo RA.”
BackgroundStruthers, A. D., Brown, D. C., Brown, M. J., Schumer, B., & Bloom, S. R. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01114.x · Cited by 28
Smoking and insulin sensitivity in type I diabetic patients
Helve, E., Yki‐Järvinen, H., & Koivisto, V. A. (1986) · Metabolism · doi:10.1016/0026-0495(86)90231-3 · Cited by 28
Battram, D. S., Graham, T. E., & Dela, F. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.130526 · Cited by 27
“Due to the fact that adrenaline decreases glucose disposal in a dose-dependent manner (Deibert & DeFronzo, 1980; Baron et al. 1987; Laurent et al. 1998), the lower adrenaline concentration in the CAF + ADR trial (0.93 versus 1.19 nm ADR alone) would be likely to result in a less inhibitory effect…”
BackgroundMethodInfluentialAssociation of obstructive sleep apnea with cardiometabolic diseases and cardiovascular mortality
Gao, J., Shi, L., Zhu, X., & Liu, J. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13666 · Cited by 29
Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?
Aurora, R. N., & Punjabi, N. M. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.03.006 · Cited by 30
HDL-cholesterol level provides additional prognosis in acute coronary syndromes
Correia, L. C. L., Rocha, M. D. S., & Esteves, J. P. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.05.067 · Cited by 32
“Catecholamines promote insulin resistance [15], decreasing the activity of lipoprotein lipase [16]what leads to a diminished HDL-cholesterol synthesis.”
BackgroundVestergaard, E. T., Møller, N., & Jørgensen, J. O. L. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2012 · Cited by 30
“Since epinephrine stimulates lipolysis (2, 8) and induces insulin resistance (4, 8), we speculate that it could be the secondary messenger, but experimental studies in human models are warranted to pursue this hypothesis.”
BackgroundPostreanimationssyndrom: Rolle der Entzündung nach Herz-Kreislauf-Stillstand
Schneider, A., Albertsmeier, M., Böttiger, B. W., & Teschendorf, P. (2012) · Der Anaesthesist · doi:10.1007/s00101-012-2002-8 · Cited by 25
Greisen, J. R., Nielsen, D. V., Sloth, E., & Jakobsen, C.-J. (2012) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2012.02731.x · Cited by 28
The Disparate Effects of Epinephrine and Norepinephrine on Hyperglycemia in Cardiovascular Surgery
Phadke, D. R., Beller, J. P., & Tribble, C. G. (2018) · The Heart Surgery Forum · doi:10.1532/hsf.2008 · Cited by 25
Bemelmans, R. H. H., Wassink, A. M. J., van der Graaf, Y., Nathoe, H. M., Vernooij, J. W. P., Spiering, W., & Visseren, F. L. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1017 · Cited by 29
Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome
Bybee, K. A., Murphy, J. G., Prasad, A., et al. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.01.016 · Cited by 25
Budohoski, L., Challiss, R. A. J., Dubaniewicz, A., Kaciuba-Uściłko, H., Leighton, B., Lozeman, F. J., Nazar, K., Newsholme, E. A., & Porta, S. (1987) · Biochemical Journal · doi:10.1042/bj2440655 · Cited by 32
Secondary diabetes mellitus in pheochromocytomas and paragangliomas
Moustaki, M., Paschou, S. Α., Vakali, E., Xekouki, P., Ntali, G., Kassi, E., Peppa, Μ., Ψαλτοπούλου, Θ., Tzanela, M., & Vryonidou, A. (2023) · Endocrine · doi:10.1007/s12020-023-03492-7 · Cited by 30
“Adrenaline is demonstrated to decrease GIR, as well as to increase endogenous glucose production (EGP) and glucagon level, upon β -AR activation [27].”
BackgroundVenkatesan, N., Davidson, M. B., Simsolo, R. B., & Kern, P. A. (1994) · Metabolism · doi:10.1016/0026-0495(94)90103-1 · Cited by 28
Corica, F. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00174-5 · Cited by 24
“ative correlation has been found between plasma catecholamines and sensitivity to insulin.(32,33) On the other hand, the physiologic increase in catecholamines induced by OGTT triggers a further synthesis of insulin and therefore potentiates the insulin-induced entrance of magnesium.”
BackgroundInterpretation of the metabolic effects of trauma and sepsis.
Stoner, H. B. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.1108 · Cited by 23
The Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Chronically elevated norepinephrine concentrations lower glucose uptake in fetal sheep
Davis, M. A., Camacho, L. E., Anderson, M. J., Steffens, N. R., Pendleton, A. L., Kelly, A. C., & Limesand, S. W. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00365.2019 · Cited by 25
The Prognostic Significance of Heart Rate for Cardiovascular Disease and Hypertension
Tjugen, T. B., Flaa, A., & Kjeldsen, S. E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0104-8 · Cited by 26
“Sympathetic overactivation leads to increased insulin resistance by adrenergic stimulation [39], resulting in a cascade of cardiovascular risk factors, atherosclerosis, and elevated BP.”
BackgroundLee, S., Min, J., & Min, K. (2020) · Nutrients · doi:10.3390/nu12061783 · Cited by 23
“Caffeine is also known to stimulate the release of catecholamines, especially epinephrine, which impairs both hepatic and peripheral insulin sensitivity [6,44].”
BackgroundLaffer, C. L., & Elijovich, F. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00423 · Cited by 23
“For epinephrine, increased lipolysis, hepatic glucogenolysis, and decreased peripheral utilization of glucose(52,53) predominate, as supported by epinephrine-induced insulin resistance in normal men at subpressor doses.(54) Clinical studies have documented a relationship between heart rate and insulin resistance in no…”
The effect of oral terbutaline on maternal glucose metabolism and energy expenditure in pregnancy
Smigaj, D., Drago, N. M., Amini, S. B., Caritis, S. N., Kalhan, S. C., & Catalano, P. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70545-9 · Cited by 22
Dierkx, R., VANDEHOEK, W., Hoekstra, J. B. L., & Erkelens, D. W. (1996) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(96)80018-0 · Cited by 29
Niklasson, M., Holmäng, A. B., & Lönnroth, P. (1998) · Diabetologia · doi:10.1007/s001250051093 · Cited by 25
“In view of the contradictory data, we studied the relation between muscle blood flow and metabolism during b-adrenergic stimulation, which is known to induce insulin resistance as well as peripheral vasodilation [1].”
BackgroundRobinson, L. E., Spafford, C., Graham, T. E., & Smith, G. N. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34147-0 · Cited by 23
Lactoferrin ameliorates corticosterone-related acute stress and hyperglycemia in rats
Maekawa, Y., Sugiyama, A., & Takeuchi, T. (2016) · Journal of Veterinary Medical Science · doi:10.1292/jvms.16-0498 · Cited by 23
“The epinephrine-induced increase in plasma glucose is thought to be brought about by enhanced output of hepatic glucose in the fed condition and attenuated glucose clearance [6, 12].”
BackgroundVicini, P., Avogaro, A., Spilker, M. E., Gallo, A., & Cobelli, C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00530.2001 · Cited by 22
“These results would contradict previous studies showing that, in the presence of Epi, EGP is significantly less inhibited by insulin (10, 23), ten- and twofold, without and with”
ResultChen, M., HALTERIN, J. B., & Porte, D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1193 · Cited by 22
Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans
Guy, D. A., Sandoval, D., Richardson, M. A., Tate, D., Flakoll, P. J., & Davis, S. N. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2004 · Cited by 21
“Limited information exists concerning the effects of epinephrine in the presence of hyperinsulinemic euglycemia in T1DM (13, 17, 35, 37).”
BackgroundKeltikangas-Järvinen, L., Ravaja, N., Räikkönen, K., & Lyytinen, H. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90033-5 · Cited by 21
Ramadas, N., Devaki, M., & Yajurvedi, H. N. (2011) · Stress · doi:10.3109/10253890.2011.619604 · Cited by 22
Petrák, O., Klímová, J., Mráz, M., Haluzíková, D., Doležalová, R., Kratochvílová, H., Lacinová, Z., Novák, K., Michalský, D., Waldauf, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa154 · Cited by 24
Cardiovascular Risk Factors Associated with Pulse Pressure in a Screened Cohort in Okinawa, Japan.
Inoue, T., Matsuoka, M., Nagahama, K., Iseki, C., Touma, T., Iseki, K., Kinjo, K., & Takishita, S. (2003) · Hypertension Research · doi:10.1291/hypres.26.153 · Cited by 21
“0001 227 (27) 199 (28) 210 (29) 314 (38) <0.”
BackgroundRegulation of amino acid metabolism by epinephrine
Prato, S. D., DeFronzo, R. A., Castellino, P., Wahren, J., & Alvestrand, A. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.5.e878 · Cited by 25
Self-citationCapaldo, B., Napoli, R., Guida, R., Bonito, P. D., Antoniello, S., Auletta, M., Pardo, F., Rendina, V., & Saccà, L. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.2.e248 · Cited by 20
Shi, Y., Pizzini, J. D., Wang, H., Das, F., Azees, P. A. A., Choudhury, G. G., Barnes, J. L., Zang, M., Weintraub, S. T., Yeh, C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00651.2020 · Cited by 27
Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance
Fischman, A. J. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.752 · Cited by 22
“Propranolol acts by inhibiting the effect of epinephrine (11,12).”
Incidence and predictive factors of hypoglycemia after pheochromocytoma resection
Araki, S., Kijima, T., Waseda, Y., Komai, Y., Nakanishi, Y., Uehara, S., Yasuda, Y., Yoshida, S., Yokoyama, M., Ishioka, J., et al. (2018) · International Journal of Urology · doi:10.1111/iju.13864 · Cited by 26
Effects of lactate infusion on hepatic gluconeogenesis and glycogenosis
Haesler, E., Schneiter, P., Temler, E., Jéquier, E., & Tappy, L. (1995) · Clinical Physiology · doi:10.1111/j.1475-097x.1995.tb00546.x · Cited by 24
Olsen, M. H. (2000) · Blood Pressure · doi:10.1080/080370500453474 · Cited by 21
“However, the relationship between changes in insulin sensitivity and circulating epinephrine is more controversial [42].”
BackgroundResultRapid fluctuations in plasma catecholamines in monkeys under undisturbed conditions
HANSEN, B. C., Schielke, G. P., Jen, K. ‐. C., Wolfe, R. A., Movahed, H., & Pek, S. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.242.1.e40 · Cited by 24
Silva, A. J., & Caron, A. (2021) · Endocrinology · doi:10.1210/endocr/bqab164 · Cited by 20
Volgin, D. V., & Kubin, L. K. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.03.013 · Cited by 20
“Elevated levels of circulating epinephrine, norepinephrine and angiotensin II suppress the inhibitory effect of insulin on glucose release, thus promoting glucose intolerance (Deibert and DeFronzo, 1980; Rizza et al., 1980; Richey et al., 1999; Vicini et al., 2002).”
BackgroundShi, Y., Shu, Z.-J., Xue, X., Yeh, C., Katz, M. S., & Kamat, A. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.005 · Cited by 20
“Studies in humans have demonstrated that adrenergic responsive stimulation of hepatic glucose output is mediated primarily through β-AR signaling (Rizza et al., 1980; Deibert and DeFronzo, 1980).”
Effect of bosentan (ET/ET receptor antagonist) on metabolic changes during stress and diabetes
SAID, S., Ammar, E. M., & Suddek, G. M. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.05.009 · Cited by 20
Myers, M. G., & de Champlain, J. (1983) · Hypertension · doi:10.1161/01.hyp.5.4.591 · Cited by 19
Extrarenal Potassium Metabolism
Sahni, V., Gmurczyk, A., & Rosa, R. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00048-3 · Cited by 19
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.